The peripheral blood immune cell profile in a teriflunomide-treated multiple sclerosis patient with COVID-19 pneumonia
نویسندگان
چکیده
منابع مشابه
COVID-19 and its Outcomes in Multiple Sclerosis Patients
Background: Coronavirus Disease 2019 (COVID-19) is a highly contagious disease that resulted in 4533645 deaths until September first, 2021. Multiple Sclerosis (MS) patients receive immunosuppressive drugs. Thus, there is a concern that these drugs will reduce the patient’s immune system resistance against COVID19. Objectives: This study aimed to evaluate the epidemiology of COVID19 and its ...
متن کاملImmunophenotyping of Immune Cells in Peripheral Blood of TB Patient with Positive Smear Before Treatment
ABSTRACT Regarding cellular immunity function and macrophage system in tuberculosis infection control and also tuberculosis high spread in Gilan province and as many studies about tuberculosis has done in chronic and acute progressive process. This study was examined thirty persons smear positive with clinical symptoms and recognition infections expert before Treatment. Tuberculosis patients ...
متن کاملPsychological Distress in Patients With Multiple Sclerosis and Epilepsy in the COVID-19 Pandemic: A Systematic Review
Background: The COVID-19 pandemic can cause various anxiety, fear, and tension in society. The negative impact of the pandemic is not limited to physical health problems. It can generate serious consequences, such as anxiety, depression, and stress, especially neurological diseases. Objectives: The present study investigated depression, anxiety, and stress in patients with MS and epilepsy dur...
متن کاملTeriflunomide for the treatment of multiple sclerosis.
Teriflunomide is a new active drug which has recently been approved as a first-line treatment of relapsing forms of MS in the US, Australia, Argentina, and the European Union. It is characterized by a once-daily oral application and a well-established long-term safety profile. The main therapeutic effect is considered to be mediated via the inhibition of the de novo synthesis of pyrimidine in p...
متن کاملTeriflunomide effect on immune response to influenza vaccine in patients with multiple sclerosis
OBJECTIVE To investigate the effect of teriflunomide on the efficacy and safety of seasonal influenza vaccine. METHODS The 2011/2012 seasonal influenza vaccine (containing H1N1, H3N2, and B strains) was administered to patients with relapsing forms of multiple sclerosis (RMS) treated for ≥6 months with teriflunomide 7 mg (n = 41) or 14 mg (n = 41), or interferon-β-1 (IFN-β-1; n = 46). The pri...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Neuroimmunology
سال: 2020
ISSN: 0165-5728
DOI: 10.1016/j.jneuroim.2020.577323